Recent Company News

• 08:02 AM ET May 18, 2026
  

  Amgen issues statement on TAVNEOS in Japan; continues to engage with US FDA (post-close 15-May) ($326.31, 0.00)

• 03:21 AM ET May 15, 2026
  

  Kissei Pharmaceutical urges healthcare professionals to refrain from using TAVNEOS (avacopan) for new patients (¥4305.0000, 0)

• 09:40 PM ET May 10, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 07:10 PM ET May 11, 2026
  

  Street Takeaways - CSL FY26 guidance downgrade (A$100.75, 0.00)

• 04:53 PM ET May 11, 2026
  

  CSL downgraded to neutral from overweight at Jarden (A$100.75, 0.00)

• 10:18 AM ET May 11, 2026
  

  CSL downgraded to neutral from buy at Citi (A$100.75, 0.00)

• 05:18 AM ET May 11, 2026
  

  CSL downgraded to hold from buy at Canaccord Genuity (A$100.75, 0.00)

• 12:58 AM ET May 11, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (54 total)

• 09:06 PM ET May 10, 2026
  

  Quick Take: CSL trading (17.7%) as guidance downgraded materially; sentiment cautious pending leadership and turnaround clarity (A$98.83, -21.05)